ESMO 2022: Pembrolizumab plus lenvatinib shows promise for non clear cell kidney cancer
The phase 2 KEYNOTE-B61 study was presented at the recent [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]
Results from the phase 3 CLEAR studywere presented at the [...]
The results of COSMIC-131 were presented at the European Society [...]
Neutrophils and eosinophils are white blood cells. In this study, [...]
In a recent phase 3 clinical trial the combination of [...]
Adjuvant therapy is medication that is given after surgery to [...]
Maintaining good health-related quality of life is important for all [...]
Preliminary results from the COSMIC-313 clinical trial have ben released. [...]
During the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
During the American Society of Clinical Oncology Annual Meeting earlier [...]